アジア太平洋地域におけるバイオテクノロジーの業界プロファイルは、市場規模（2019〜2024年の価値、および2029年までの予測）を含む、定性的および定量的な概要情報を提供します。また、主要財務指標を含む主要プレーヤーの説明と、市場における競争圧力の分析も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. Takeda Pharmaceutical Co Ltd
8.2. Astellas Pharma Inc
8.3. BeiGene Ltd
8.4. Kyowa Kirin Co Ltd
8.5. Chugai Pharmaceutical Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Asia-Pacific biotechnology industry value: $ million, 2019-24
Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2019-24
Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2024
Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2024-29
Table 6: Takeda Pharmaceutical Co Ltd: Key Facts
Table 7: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Co Ltd: Key Employees
Table 9: Astellas Pharma Inc: Key Facts
Table 10: Astellas Pharma Inc: Annual Financial Ratios
Table 11: Astellas Pharma Inc: Key Employees
Table 12: BeiGene Ltd: Key Facts
Table 13: BeiGene Ltd: Annual Financial Ratios
Table 14: BeiGene Ltd: Key Employees
Table 15: BeiGene Ltd: Key Employees Continued
Table 16: Kyowa Kirin Co Ltd: Key Facts
Table 17: Kyowa Kirin Co Ltd: Annual Financial Ratios
Table 18: Kyowa Kirin Co Ltd: Key Employees
Table 19: Kyowa Kirin Co Ltd: Key Employees Continued
Table 20: Chugai Pharmaceutical Co Ltd: Key Facts
Table 21: Chugai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 22: Chugai Pharmaceutical Co Ltd: Key Employees
Table 23: Asia-Pacific Exchange Rate, 2019-24
List of Figures
Figure 1: Asia-Pacific biotechnology industry value: $ million, 2019-24
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2024
